Health Canada Ponders UK Model On Easing Biosimilar Study Requirements
US FDA Stand Unchanged For Now
Panelists At AAM (From Left To Right) - Aaron Josephson, Teva Pharma; Hillel Cohen, Sandoz; Celia Lourenco, Health Canada; Stacey Ricci, FDA; Cory Wohlbach, Teva Pharma • Source: Association For Accessible Medicines 
